Nuvilex (OTCQB: NVLX) recently announced favorable results of a completed Phase 2 clinical trial carried out in Europe to combat Pancreatic Cancer. The Company announced last week that it had acquired that the treatment technology which involves the use of encapsulated cells.

Another drug stock that I really like is Endo Pharmaceuticals (ENDP). Endo Pharmaceuticals is a midcap biotechnology company that is know for developing and selling pain management drugs and therapies. This company may be a good investment as a play on an aging baby boomer population. The generic pharmaceutical market is a highly profitable market as drug patents expire from bigger name players.

Drugstore.com, Inc. (NASD: DSCM), a leading online provider of health, beauty, vision, and pharmacy products, recently reported its financial results for the third quarter ended September 28, 2008. The company reported an 8.5 percent year-over-year increase in quarterly sales to $87.8 million and a net loss of $3.6 million, or a loss of $0.04 per share.

BioScrip, Inc., the specialty pharmacy and pharmacy services provider, had a double dose of good news today with the announcement of exceptional second quarter revenue and earnings figures. Consolidated revenue grew to $348.4 million, an 18.2% increase over the same period last year. Specialty Services revenue shot up to $298.2 million, a 25.3% over the prior year.